Attached files
| file | filename |
|---|---|
| EX-10.50 - LOAN AGREEMENT AND NOTE PAYABLE DATED JANUARY 13, 2017 - Cell MedX Corp. | cmxc_ex1050.htm |
| EX-32.2 - Cell MedX Corp. | cmxc_ex322.htm |
| EX-31.2 - CERTIFICATION - Cell MedX Corp. | cmxc_ex312.htm |
| EX-31.1 - CERTIFICATION - Cell MedX Corp. | cmxc_ex311.htm |
| EX-21.1 - LIST OF SUBSIDIARIES - Cell MedX Corp. | cmxc_ex211.htm |
| EX-10.54 - LOAN AGREEMENT AND NOTE PAYABLE DATED MAY 5, 2017 - Cell MedX Corp. | cmxc_ex1054.htm |
| EX-10.53 - LOAN AGREEMENT AND NOTE PAYABLE DATED APRIL 18, 2017 - Cell MedX Corp. | cmxc_ex1053.htm |
| EX-10.52 - LOAN AGREEMENT AND NOTE PAYABLE DATED MARCH 8, 2017 - Cell MedX Corp. | cmxc_ex1052.htm |
| EX-10.51 - LOAN AGREEMENT AND NOTE PAYABLE DATED FEBRUARY 14, 2017 - Cell MedX Corp. | cmxc_ex1051.htm |
| EX-10.49 - LOAN AGREEMENT AND NOTE PAYABLE DATED JANUARY 11, 2017 - Cell MedX Corp. | cmxc_ex1049.htm |
| 10-K - ANNUAL REPORT - Cell MedX Corp. | cmxc_10k.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Cell MedX Corp. (the “Company”) on Form 10-K for the period ending May 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Frank McEnulty, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: August 29, 2017
/s/Frank McEnulty
Frank McEnulty
Chief Executive Officer